CN Patent

CN108721214B — 奈妥吡坦和帕洛诺司琼复方纳米粒溶液、纳米粒及制备方法和用途

Assigned to Beijing Funhau Medical Technology Co ltd · Expires 2020-06-16 · 6y expired

What this patent protects

本发明属于医药领域，具体涉及以奈妥吡坦和帕洛诺司琼为活性成分制备得到的一种新型高效的止吐复方药物奈妥吡坦和帕洛诺司琼复方载药纳米粒、纳米粒溶液。本发明所要解决的技术问题是改善奈妥吡坦和帕洛诺司琼的水溶性、使药物在体内达到缓释作用，提高药物的生物利用、改变药物体内分布，提高疗效。为实现奈妥吡坦与帕洛诺司琼复方制剂可做成多种剂型提供了新方法和新思路。该复方纳米粒具有水溶性好、粒度均匀、性状稳定、冻干易复溶、易吸收、可静脉注射等优点。

USPTO Abstract

本发明属于医药领域，具体涉及以奈妥吡坦和帕洛诺司琼为活性成分制备得到的一种新型高效的止吐复方药物奈妥吡坦和帕洛诺司琼复方载药纳米粒、纳米粒溶液。本发明所要解决的技术问题是改善奈妥吡坦和帕洛诺司琼的水溶性、使药物在体内达到缓释作用，提高药物的生物利用、改变药物体内分布，提高疗效。为实现奈妥吡坦与帕洛诺司琼复方制剂可做成多种剂型提供了新方法和新思路。该复方纳米粒具有水溶性好、粒度均匀、性状稳定、冻干易复溶、易吸收、可静脉注射等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN108721214B
Jurisdiction
CN
Classification
—
Expires
2020-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Funhau Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.